Andrew Berchuck mainly focuses on Ovarian cancer, Cancer research, Internal medicine, Cancer and Pathology. Andrew Berchuck interconnects Case-control study, Carcinoma, Serous fluid and Ovary in the investigation of issues within Ovarian cancer. His Cancer research research incorporates themes from Immunohistochemistry and Mutation, Tumor suppressor gene, Gene, Carcinogenesis.
His Internal medicine research includes themes of Gastroenterology, Macrophage colony-stimulating factor, Endocrinology and Oncology. Andrew Berchuck has included themes like Survival rate, Radiation therapy, Surgery and Bioinformatics in his Cancer study. His study looks at the intersection of Pathology and topics like Laminin with Cancer cell.
Ovarian cancer, Internal medicine, Oncology, Cancer research and Cancer are his primary areas of study. The Ovarian cancer study which covers Gynecology that intersects with Risk factor. His Internal medicine study combines topics from a wide range of disciplines, such as Endocrinology and Pathology.
His Oncology research integrates issues from Bioinformatics, Disease, Epithelial ovarian cancer, Stage and Breast cancer. His Cancer research research incorporates elements of Gene expression, Gene, DNA methylation, Ovary and Tumor suppressor gene. He studies Carcinogenesis, a branch of Cancer.
Andrew Berchuck focuses on Ovarian cancer, Internal medicine, Oncology, Genome-wide association study and Cancer research. Cancer covers Andrew Berchuck research in Ovarian cancer. His work carried out in the field of Oncology brings together such families of science as Odds ratio, Gene, Proportional hazards model, Breast cancer and Endometrial cancer.
The various areas that Andrew Berchuck examines in his Genome-wide association study study include Genetic correlation, Genotyping, Allele and Genetic association. In his study, Methylation, Epigenetics and Regulation of gene expression is strongly linked to DNA methylation, which falls under the umbrella field of Cancer research. As a part of the same scientific study, Andrew Berchuck usually deals with the Serous fluid, concentrating on Ovarian carcinoma and frequently concerns with Adenocarcinoma.
His primary areas of study are Ovarian cancer, Oncology, Internal medicine, Genome-wide association study and Cancer research. His Ovarian cancer study integrates concerns from other disciplines, such as Bioinformatics, Serous fluid, Gynecology, Breast cancer and Single-nucleotide polymorphism. His research in Serous fluid intersects with topics in Ovarian carcinoma, Serous carcinoma and Allele.
His Oncology research is multidisciplinary, relying on both Odds ratio, Cancer, Prostate cancer and Carcinoma. In general Internal medicine, his work in Prostate, Case-control study, Stage and Proportional hazards model is often linked to Risk assessment linking many areas of study. His study in Cancer research is interdisciplinary in nature, drawing from both DNA methylation, Oncogene, Transcription factor, Chromatin and microRNA.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Integrated genomic analyses of ovarian carcinoma
D. Bell;A. Berchuck;M. Birrer;J. Chien.
Integrated genomic characterization of endometrial carcinoma
Gad Getz;Stacey B. Gabriel;Kristian Cibulskis;Eric Lander.
Oncogenic pathway signatures in human cancers as a guide to targeted therapies.
Andrea H. Bild;Guang Yao;Jeffrey T. Chang;Quanli Wang.
BRCA1 mutations in primary breast and ovarian carcinomas
P. Andrew Futreal;Qingyun Liu;Donna Shattuck-Eidens;Charles Cochran.
Pan-cancer analysis of whole genomes
Peter J. Campbell;Gad Getz;Jan O. Korbel;Joshua M. Stuart.
Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer
Zhen Zhang;Robert C. Bast;Yinhua Yu;Jinong Li.
Cancer Research (2004)
Rethinking ovarian cancer: recommendations for improving outcomes
Sebastian Vaughan;Jermaine I. Coward;Robert C. Bast;Andy Berchuck.
Nature Reviews Cancer (2011)
Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancer.
A. Berchuck;R. Whitaker;G. Olt;J. T. Soper.
Cancer Research (1990)
Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk
Ganna Chornokur;Hui-Yi Lin;Jonathan P. Tyrer;Kate Lawrenson.
PLOS ONE (2015)
Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies.
Celeste Leigh Pearce;Claire Templeman;Mary Anne Rossing;Alice Lee.
Lancet Oncology (2012)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: